Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
NIKKEI 225
38,236.07
-37.98
(-0.10%)
HANG SENG
18,207.13
+444.10
(+2.50%)
CRUDE OIL
79.09
+0.09
(+0.11%)
GOLD FUTURES
2,314.10
+3.10
(+0.13%)
DOW
38,199.81
+296.52
(+0.78%)
Bitcoin GBP
47,147.14
+1,191.88
(+2.59%)
Money
Best UK mortgage deals of the week
The cheapest home loans available now
Intra-Cellular Therapies, Inc. (ITCI)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
70.49
-2.24
(-3.08%)
As of 03:34PM EDT. Market open.
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
462,175
462,175
249,132
81,708
22,531
Cost of revenue
33,745
33,745
20,443
8,035
1,895
Gross profit
428,430
428,430
228,689
73,673
20,636
Operating expenses
Research development
180,142
180,142
134,715
88,845
65,782
Selling general and administrative
409,864
409,864
358,782
272,611
186,364
Total operating expenses
587,811
587,811
492,315
359,361
251,864
Operating income or loss
-159,381
-159,381
-263,626
-285,688
-231,228
Income before tax
-139,038
-139,038
-256,250
-284,120
-226,992
Income tax expense
636
636
6
6
14
Income from continuing operations
-139,674
-139,674
-256,256
-284,126
-227,006
Net income
-139,674
-139,674
-256,256
-284,126
-227,006
Net income available to common shareholders
-139,674
-139,674
-256,256
-284,126
-227,006
Basic EPS
-1.62
-
-2.72
-3.50
-3.23
Diluted EPS
-1.62
-
-2.72
-3.50
-3.23
Basic average shares
95,499
-
94,047
81,253
70,365
Diluted average shares
95,499
-
94,047
81,253
70,365
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.